SCHEMBL13625943

SCHEMBL13625943

CCCCc1nc(C)n(-c2ccc(O)c(O)c2)c(=O)c1Cc1ccc(-c2ccccc2C#N)cc1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.41
ACHE P22303 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14136139 0.93 APLNR (0.40) APLNRACHE
SCHEMBL1892641 0.91 APLNR (0.42) APLNRACHE
SCHEMBL1895774 0.90 APLNR (0.42) APLNRACHE
SCHEMBL1892788 0.90 ACHE (0.42) ACHE
SCHEMBL1893224 0.90 ACHE (0.42) ACHE
SCHEMBL1889595 0.89 ACHE (0.43) ACHE
SCHEMBL2871115 0.89 ACHE (0.45) ACHE
SCHEMBL1893191 0.88 ACHE (0.42) APLNRACHE
SCHEMBL4016632 0.88 APLNR (0.40) APLNRACHE
SCHEMBL2872526 0.88 PPARG (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed